These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 15219283)

  • 1. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
    Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
    Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent.
    Wängler B; Beck C; Shiue CY; Schneider S; Schwanstecher C; Schwanstecher M; Feilen PJ; Alavi A; Rösch F; Schirrmacher R
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5205-9. PubMed ID: 15380228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
    Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
    Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
    Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
    Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans.
    Schneider S; Feilen PJ; Schreckenberger M; Schwanstecher M; Schwanstecher C; Buchholz HG; Thews O; Oberholzer K; Korobeynikov A; Bauman A; Comagic S; Piel M; Schirrmacher E; Shiue CY; Alavi AA; Bartenstein P; Rösch F; Weber MM; Klein HH; Schirrmacher R
    Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):388-95. PubMed ID: 16025400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
    Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
    J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.
    Hansen AM; Christensen IT; Hansen JB; Carr RD; Ashcroft FM; Wahl P
    Diabetes; 2002 Sep; 51(9):2789-95. PubMed ID: 12196472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
    Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
    J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorosulfate for PET Imaging of the Sodium-Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo.
    Khoshnevisan A; Chuamsaamarkkee K; Boudjemeline M; Jackson A; Smith GE; Gee AD; Fruhwirth GO; Blower PJ
    J Nucl Med; 2017 Jan; 58(1):156-161. PubMed ID: 27539841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation in rats of [(18)F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptors.
    Waterhouse RN; Chang RC; Zhao J; Carambot PE
    Nucl Med Biol; 2006 Feb; 33(2):211-5. PubMed ID: 16546675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
    Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM
    Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
    Zhang W; Kung MP; Oya S; Hou C; Kung HF
    Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[(18) F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET.
    Mou T; Zhao Z; You L; Wang Q; Fang W; Lu J; Peng C; Zhang X
    J Labelled Comp Radiopharm; 2015 Jun; 58(8):349-54. PubMed ID: 26094722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D; Winkler M; Kühner P; Russ U; Quast U
    Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.